DocGo Investor Presentation Deck
Q3 2022 FINANCIAL UPDATE
($ in millions)
$13.4
($4.1)
139%
YOY
('22 v. '21)
DOCGO
$49.7
$0.4
Q1
Q1
117.9
13.6
© 2023 All Rights Reserved - DocGo
$22.6
($0.2)
76%
YOY
('22 v. '21)
$62.2
Q2
$3.4
Q2
Revenue
109.5
12.3
$26.9
Q3
2020 2021 2022
Adjusted EBITDA
11 OG
22%
YoY
(22 v. '21)
($0.9)
$85.8
$4.0
Q3
2020 2021 2022
$104.3
$8.4
$31.2
288%
YoY
('21 v. '20)
$121.3
Q4
($2.9)
GO
$17.3
Q4
3rd Quarter 2022 Financial Highlights
Total revenue increased by 22% YOY to 104.3 million
Ex-mass Covid testing, Q3 Mobile Health revenues grew
75% YOY and 18% sequentially
Adjusted EBITDA increased by 110% YOY to $8.4 million
• Mobile Health revenue increased 12.9% YOY to $76.6
million
●
●
●
●
3rd Quarter 2022 Business Highlights
Expanded partnership with Gary and Mary West PACE
(West PACE) to launch remote patient monitoring (RPM) to
enhance care for PACE participants aged 55 and older
within the San Diego market.
●
●
DOCGO
Transportation Services revenue increased 55% YOY to
$27.7 million
Announced its mobile health services are now available to
Cigna commercial customers in New York and New Jersey,
beginning October 1, 2022.
Announced that its UK-based subsidiary, Ambulnz
Community Partners, has been awarded three new
contracts, continuing to drive growth in Greater
Manchester while also expanding services in Lancashire
and Merseyside.
Executed a new contract to provide mobile health services
to Horizon Healthcare Services, Inc. (Horizon) members,
covering commercial and Medicare members in New
Jersey. The agreement allows DocGo to potentially reach
an additional 3.8 million people.
Booke
D
GO
19
→View entire presentation